The Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged...

Maharashtra FDA has launched a statewide crackdown on Ayurvedic drug manufacturers. Inspections revealed serious violations of manufacturin...

The Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...

India’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...

CREDAI West Bengal welcomes the state government's proposed Standard Operating Procedure for building safety. Developers requested an eight...

India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

HYBE, home to BTS, is expanding its global operations into India. The company sees India as a dynamic music ecosystem with significant grow...

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...

A parliamentary committee has recommended an integrated security system for Jammu and Kashmir's tourist sites. This system will include CCT...

To bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...

The panel suggested the commerce department prepare a time-bound roadmap to achieve the objectives of the Mission 500 initiative by promoti...

Commerce and Industry Minister Piyush Goyal urged India and Uzbekistan to double bilateral trade from the current $1.5 billion within three...

Maharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...

Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....